Skip to main content

Table 3 The detailed clinical postoperative course of the propensity-matched patients of the Redo-TAVI and Redo-AVR group

From: Propensity matched analysis of longterm outcomes following transcatheter based aortic valve implantation versus classic aortic valve replacement in patients with previous cardiac surgery

  All patients Propensity-matched patients
  Redo-TAVI (n = 52) Redo-AVR (n = 167) p value Redo-TAVI (n = 40) Redo-AVR (n = 40) p value
Variables No. (%) No. (%)   No. (%) No. (%)  
Ventilation time (h) 8 ± 6 18 ± 24 0.07 9 ± 7 31 ± 41 0.04
ICU stay (h) 25 ± 21 65 ± 68 0.04 23 ± 20 74 ± 97 0.03
Postoperative complications  
 Bleeding complications  
 Postop. chest tube drainage (ml/24 h)§ 144 ± 209 580 ± 420 0.05 163 ± 214 562 ± 332 0.02
 Surgical reexploration 2 (4) 13 (8) 0.09 1 (3) 7 (17) 0.05
Transfusion rate of allogenic  
 Blood products  
 PRBC (U)|| 1 ± 1 6 ± 6 0.03 1 ± 1 6 ± 6 0.04
 FFP (U)* 1 ± 1 5 ± 5 0.04 1 ± 1 4 ± 3 0.05
 PC (U) 0 4 ± 2 0.01 0 4 ± 1 0.01
 Low cardiac output 2 (4) 4 (2) 0.23 2 (5) 2 (5) >0.99
Acute kidney injury  
Creatinin increase >300% 3 (5) 6 (4) 0.18 1 (3) 2 (5) 0.09
Permanent PM implantation^ 1 (2) 5 (3) 0.21 0 3 (8) 0.31
Cerebrovascular  
 TIA 2 (4) 4 (2) 0.23 1 (3) 2 (5) 0.09
 Major stroke (Rankin score >2) 0 7 (4) 0.07 0 5 (13) 0.04
Wound healing disorder  
 Conservative treatment 0 11 (7) 0.04 0 2 (5) 0.06
 Surgical treatment 0 6 (4) 0.05 0 1 (3) 0.07
 Thirty day mortality 3 (6) 14 (8) 0.14 3 (8) 6 (16) 0.06
  1. *FFP = fresh-frozen plasma; ICU = intensive care unit; PC = Platelet cells; §Postop. = Postoperative; ||PRBC = packed red blood cells; ^PM = pace maker; TIA = Transient ischemic attack.